
Shoulder & Elbow
AAOS2018: Additional liposomal bupivacaine infiltration to ISBPB of no benefit in TSA
75 patients scheduled for total shoulder arthroplasty under an interscalene brachial plexus block were randomized to either receive or not receive additional intraoperative infiltration of liposomal bupivacaine within the periarticular soft tissues. Patients were assessed for narcotic consumption over the first 24 hours after surgery, and pain scores over the first 72 hours postoperatively. Results on total morphine equivalents in the first 24 hours demonstrated significantly higher consumption among patients administered the periarticular liposomal bupivacaine infiltration compared to those who were not. Pain scores did not significantly differ between groups at any time point up to 72 hours postoperatively.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now

Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.